Search
Showing results for "1"
Research
Neuroanatomical heterogeneity and homogeneity in individuals at clinical high risk for psychosisIndividuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profiles and outcome features. However, the extent of neuroanatomical heterogeneity in the CHR-P state is largely undetermined.
News & Events
Ads clinic updateThe Perth Children’s Hospital (PCH) Adolescent Diabetes Service (ADS) clinics have had several updates thanks to your feedback, including the introduction of “Welcome to Ads group sessions” for teenagers.
News & Events
Research finds pumps deliver better long-term blood glucose controlNew research from the Children’s Diabetes Centre at The Kids Research Institute Australia has found children who use an insulin pump to manage their type 1 diabetes have better long-term blood glucose control than those on insulin injections.
Research
'If I Wanted to Have More Opportunities and Go to a Better School, I Just Had to Get Used to It’The experiences of 32 male Aboriginal students from regional and remote towns and communities while they attended a metropolitan boarding school...
Research
Changes in thymic regulatory T-cell maturation from birth to puberty: Differences in atopic childrenWe report vaccine efficacy against CIN3+ and adenocarcinoma in situ (AIS) in the end-of-study analysis of PATRICIA (PApilloma TRIal against Cancer In young...
News & Events
Recruitment for AdDIT now completeYoung people diagnosed with Type 1 Diabetes are at risk of complications from their diabetes including kidney, heart, eye and vascular disease.
Research
Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 yearsWe report data from the interim analysis of the ongoing VIVIANE study, the aim of which is to assess the efficacy, safety, and immunogenicity of the HPV...
Research
Meningococcal serogroup B-specific responses after vaccination with bivalent rLP2086Assessment of the persistence of bactericidal antibodies up to 4 years after a three-dose schedule of bivalent rLP2086